Heleia Roca-Ho

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Acute Myeloid Leukemia

Tyrosine Kinase

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Belen Lopez-Millan, Paula Costales, Francisco Gutiérrez-Agüera, Rafael Díaz de la Guardia, Heleia Roca-Ho, Meritxell Vinyoles, Alba Rubio-Gayarre, Rémi Safi, Julio Castaño, Paola Alejandra Romecín, Manuel Ramírez, Eduardo Anguita, Irmela Jeremias, Lurdes Zamora, Juan Carlos Rodríguez-Manzaneque, Clara Bueno, Francisco Morís, Pablo Menendez
The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia. Cancers 14 (6) (2022)
Rafael Díaz de la Guardia, Talía Velasco-Hernandez, Francisco Gutiérrez-Agüera, Heleia Roca-Ho, William C Earnshaw, Cesar Nombela-Arrieta, Alex Bataller, Jose-Luis Fuster, Eduardo Anguita, Susana Vives, Lurdes Zamora, Josep F Nomdedéu, María-Teresa Gómez-Casares, Manuel Ramírez-Orellana, Helene Lapillonne, Verónica Ramos-Mejía, Juan Carlos Rodríguez-Manzaneque, Clara Bueno, Belen Lopez-Millan, Pablo Menéndez
Engraftment characterization of risk-stratified AML in NSGS mice. Blood advances 5 (23) (2022)